Is Repro Med Stock a Good Investment?
Repro Med Investment Advice | KRMD |
- Examine Repro Med's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Repro Med's leadership team and their track record. Good management can help Repro Med navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Repro Med's business and its evolving consumer preferences.
- Compare Repro Med's performance and market position to its competitors. Analyze how Repro Med is positioned in terms of product offerings, innovation, and market share.
- Check if Repro Med pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Repro Med's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Repro Med Systems stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Repro Med Systems is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Repro Med Stock
Researching Repro Med's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 58.0% of the company shares are owned by institutional investors. The book value of Repro Med was now reported as 0.45. The company recorded a loss per share of 0.3. Repro Med Systems had not issued any dividends in recent years.
To determine if Repro Med is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Repro Med's research are outlined below:
| Repro Med Systems had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 28.52 M. Net Loss for the year was (13.74 M) with profit before overhead, payroll, taxes, and interest of 15.37 M. | |
| Repro Med Systems currently holds about 18.27 M in cash with (4.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Roughly 58.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 |
Repro Med Quarterly Accounts Payable |
|
Repro Med uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Repro Med Systems. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Repro Med's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Repro Med's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Repro Med's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2019-04-30 | 2019-03-31 | 0.01 | 0.0196 | 0.0096 | 96 | ||
2024-03-13 | 2023-12-31 | -0.04 | -0.03 | 0.01 | 25 | ||
2023-08-09 | 2023-06-30 | -0.06 | -0.05 | 0.01 | 16 | ||
2022-03-02 | 2021-12-31 | -0.03 | -0.02 | 0.01 | 33 | ||
2021-08-11 | 2021-06-30 | -0.02 | -0.03 | -0.01 | 50 | ||
2021-03-23 | 2020-12-31 | -0.01 | -0.02 | -0.01 | 100 | ||
2020-11-03 | 2020-09-30 | 0.02 | 0.01 | -0.01 | 50 | ||
2019-11-05 | 2019-09-30 | 0.01 | 0.02 | 0.01 | 100 |
Repro Med Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Repro target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Repro Med's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most Repro analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Repro stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Repro Med Systems, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationRepro Med Target Price Projection
Repro Med's current and average target prices are 2.19 and 4.30, respectively. The current price of Repro Med is the price at which Repro Med Systems is currently trading. On the other hand, Repro Med's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Repro Med Target Price
Repro Med Analyst Ratings
Repro Med's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Repro Med stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Repro Med's financials, market performance, and future outlook by experienced professionals. Repro Med's historical ratings below, therefore, can serve as a valuable tool for investors.Know Repro Med's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Repro Med is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Repro Med Systems backward and forwards among themselves. Repro Med's institutional investor refers to the entity that pools money to purchase Repro Med's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Keybank National Association | 2023-12-31 | 216.2 K | Empire Financial Management Company, Llc | 2023-12-31 | 107 K | Washington Trust Co | 2023-12-31 | 100 K | Bank Of New York Mellon Corp | 2023-12-31 | 97.7 K | Pnc Financial Services Group Inc | 2023-12-31 | 97 K | Charles Schwab Investment Management Inc | 2023-12-31 | 92.7 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 75.6 K | Lakewood Asset Management Llc | 2023-12-31 | 59.9 K | White Pine Capital Llc | 2023-12-31 | 56.1 K | First Light Asset Management, Llc | 2023-12-31 | 5.2 M | Archon Capital Management Llc | 2023-12-31 | 3.7 M |
Repro Med's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 102 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Repro Med's market, we take the total number of its shares issued and multiply it by Repro Med's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Repro Med's profitablity analysis
Repro Med's profitability indicators refer to fundamental financial ratios that showcase Repro Med's ability to generate income relative to its revenue or operating costs. If, let's say, Repro Med is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Repro Med's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Repro Med's profitability requires more research than a typical breakdown of Repro Med's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.50) | (0.47) | |
| Return On Capital Employed | (0.43) | (0.41) | |
| Return On Assets | (0.48) | (0.46) | |
| Return On Equity | (0.68) | (0.64) |
Determining Repro Med's profitability involves analyzing its financial statements and using various financial metrics to determine if Repro Med is a good buy. For example, gross profit margin measures Repro Med's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Repro Med's profitability and make more informed investment decisions.
The data published in Repro Med's official financial statements usually reflect Repro Med's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Repro Med Systems. For example, before you start analyzing numbers published by Repro accountants, it's critical to develop an understanding of what Repro Med's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Repro Med's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Repro Med's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Repro Med's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Repro Med Systems. Please utilize our Beneish M Score to check the likelihood of Repro Med's management manipulating its earnings.
Evaluate Repro Med's management efficiency
Repro Med Systems has return on total asset (ROA) of (0.1813) % which means that it has lost $0.1813 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5318) %, meaning that it created substantial loss on money invested by shareholders. Repro Med's management efficiency ratios could be used to measure how well Repro Med manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.47. The current year's Return On Capital Employed is expected to grow to -0.41. At present, Repro Med's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 103.9 K, whereas Return On Tangible Assets are projected to grow to (0.47).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.45 | 0.47 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 0.43 | 0.45 | |
| Enterprise Value Over EBITDA | (11.19) | (10.63) | |
| Price Book Value Ratio | 5.51 | 5.79 | |
| Enterprise Value Multiple | (11.19) | (10.63) | |
| Price Fair Value | 5.51 | 5.79 | |
| Enterprise Value | 105.1 M | 110.4 M |
The analysis of Repro Med's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Repro Med's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Repro Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.527 |
Basic technical analysis of Repro Stock
As of the 27th of April, Repro Med holds the Coefficient Of Variation of 2817.37, semi deviation of 3.13, and Risk Adjusted Performance of 0.0302. Repro Med Systems technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We have collected data for nineteen technical drivers for Repro Med Systems, which can be compared to its competitors. Please check Repro Med Systems treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Repro Med Systems is priced some-what accurately, providing market reflects its current price of 2.19 per share. Please also confirm Repro Med Systems total risk alpha, which is currently at (0.31) to check out the company can sustain itself at a future point.Repro Med's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Repro Med insiders, such as employees or executives, is commonly permitted as long as it does not rely on Repro Med's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Repro Med insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cascella Robert over three weeks ago Acquisition by Cascella Robert of 6329 shares of Repro Med at 2.37 subject to Rule 16b-3 | ||
French Donna over a month ago Acquisition by French Donna of 4310 shares of Repro Med at 3.48 subject to Rule 16b-3 | ||
Wholihan Edward over three months ago Acquisition by Wholihan Edward of 6329 shares of Repro Med subject to Rule 16b-3 | ||
Wholihan Edward over six months ago Repro Med exotic insider transaction detected | ||
Linda Tharby over six months ago Purchase by Linda Tharby of 5272 shares of Repro Med |
Understand Repro Med's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Repro Med's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0302 | |||
| Market Risk Adjusted Performance | 0.4463 | |||
| Mean Deviation | 2.34 | |||
| Semi Deviation | 3.13 | |||
| Downside Deviation | 3.36 | |||
| Coefficient Of Variation | 2817.37 | |||
| Standard Deviation | 3.25 | |||
| Variance | 10.59 | |||
| Information Ratio | 0.0081 | |||
| Jensen Alpha | 0.0863 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0078 | |||
| Treynor Ratio | 0.4363 | |||
| Maximum Drawdown | 19.41 | |||
| Value At Risk | (6.07) | |||
| Potential Upside | 5.39 | |||
| Downside Variance | 11.32 | |||
| Semi Variance | 9.79 | |||
| Expected Short fall | (2.46) | |||
| Skewness | 0.2697 | |||
| Kurtosis | 1.93 |
| Risk Adjusted Performance | 0.0302 | |||
| Market Risk Adjusted Performance | 0.4463 | |||
| Mean Deviation | 2.34 | |||
| Semi Deviation | 3.13 | |||
| Downside Deviation | 3.36 | |||
| Coefficient Of Variation | 2817.37 | |||
| Standard Deviation | 3.25 | |||
| Variance | 10.59 | |||
| Information Ratio | 0.0081 | |||
| Jensen Alpha | 0.0863 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0078 | |||
| Treynor Ratio | 0.4363 | |||
| Maximum Drawdown | 19.41 | |||
| Value At Risk | (6.07) | |||
| Potential Upside | 5.39 | |||
| Downside Variance | 11.32 | |||
| Semi Variance | 9.79 | |||
| Expected Short fall | (2.46) | |||
| Skewness | 0.2697 | |||
| Kurtosis | 1.93 |
Consider Repro Med's intraday indicators
Repro Med intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Repro Med stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Repro Med Corporate Filings
8K | 11th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 1st of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 28th of March 2024 Other Reports | ViewVerify | |
| 18th of March 2024 Other Reports | ViewVerify |
Repro Stock media impact
Far too much social signal, news, headlines, and media speculation about Repro Med that are available to investors today. That information is available publicly through Repro media outlets and privately through word of mouth or via Repro internal channels. However, regardless of the origin, that massive amount of Repro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Repro Med news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Repro Med relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Repro Med's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Repro Med alpha.
Repro Med Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Repro Med can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Repro Med without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Repro Med Corporate Management
Elected by the shareholders, the Repro Med's board of directors comprises two types of representatives: Repro Med inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Repro. The board's role is to monitor Repro Med's management team and ensure that shareholders' interests are well served. Repro Med's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Repro Med's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian Case | Chief Officer | Profile | |
| Thomas Adams | Chief Officer | Profile | |
| Rob Cannon | Vice Sales | Profile | |
| Josh Bennett | VP Devel | Profile | |
| Kenneth Miller | Chief Officer | Profile | |
| Tom Adams | Interim Officer | Profile |
How to buy Repro Stock?
To provide specific investment advice or recommendations on Repro Med Systems stock, we recommend investors consider the following general factors when evaluating Repro Med Systems. This will help you to make an informed decision on whether to include Repro Med in one of your diversified portfolios:- Examine Repro Med's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Repro Med's leadership team and their track record. Good management can help Repro Med navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Repro Med's business and its evolving consumer preferences.
- Compare Repro Med's performance and market position to its competitors. Analyze how Repro Med is positioned in terms of product offerings, innovation, and market share.
- Check if Repro Med pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Repro Med's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Repro Med Systems stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Repro Med Systems is a good investment.
Already Invested in Repro Med Systems?
The danger of trading Repro Med Systems is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Repro Med is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Repro Med. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Repro Med Systems is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Repro Med Systems is a strong investment it is important to analyze Repro Med's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Repro Med's future performance. For an informed investment choice regarding Repro Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Repro Med Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Repro Stock analysis
When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Repro Med's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (0.30) | Revenue Per Share 0.625 | Quarterly Revenue Growth (0.02) | Return On Assets (0.18) |
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Repro Med's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.